相关实验视频

Updated: Jul 23, 2025

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

优化电生理学研究,以防止心肌梗塞后心脏突然死亡

Joshua G Kovoor^1,2, Tejas Deshmukh^3,4, Amy von Huben^3,4

¹University of Adelaide, North Terrace, Adelaide, South Australia, 5005, Australia.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

|July 20, 2023

概括

心肌梗塞 (MI) 后的电生理学研究 (EPS) 发现预测了未来的腹腔动脉节律障碍. 在EPS期间较短的外刺激合间隔表明自发腹腔动脉节律失常和死亡的风险较高.

科学领域:

心脏病学心脏病学
电子生理学电子生理学
临床研究临床研究

背景情况:

心肌梗塞 (MI) 幸存者左心室喷射分数 (LVEF) 降低,患心室动脉节律失常的风险较高.
电生理学研究 (EPS) 对这些患者的风险分层至关重要.

研究的目的:

评估电生理学研究 (EPS) 参数与心肌梗塞 (MI) 后的长期结果之间的关联.
具体来说,要确定最小的最终超刺激合间隔和诱导腹腔动心率 (VT) 的起源地点是否预测自发腹腔动心率和死亡率.

主要方法:

对LVEF≤40%的患者进行前性研究,在心脏病发作后3-5天接受EPS.
外刺激合间隔逐渐缩短,以诱导静脉或确定心室折射率.
记录了静脉瘤形态和诱导参数.
长期自发腹腔动脉节律失常的发生和所有原因的死亡率被跟踪.

主要成果:

在EPS期间较短的最终外刺激合间隔与自发腹腔动脉节律失常 (P < 0.001) 的风险增加显著相关.
最后合间隔小于200毫秒的患者自发腹腔动脉节律失常的发生率明显更高 (65.2%对23.2%;P<0.001).
诱导VT与右捆分支块形态,暗示左心室起源,与增加的全因死亡率 (HR 3.2,P = 0.044) 和VT复发或死亡的复合 (HR 1.8,P = 0.043) 相关.

结论:

在心脏病发作后的早期EPS期间的最终超刺激合间隔是未来心室动脉节律失常症的重要预测因素.
根据心室折射率来确定此间隔对于准确的风险评估至关重要.
由RBBB形态学确定的来自左心室的VT预示着更糟糕的预后,包括增加死亡风险.

关键词:

可植入的心脏转换器除器合间隔时间是合间隔时间.电子生理学研究研究电子生理学研究突然的心脏病死亡.腹腔动脉短心症是因为心室短心.

更多相关视频

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Published on: May 22, 2018

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

相关概念视频

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...